Here are relevant reports on : global-ticketing-market
-
Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2030
The next-generation sequencing market, valued at USD 13.95 billion in 2024, stood at USD 14.94 billion in 2025 and is projected to advance at a resilient CAGR of 14.6% from 2025 to 2030, culminating in a forecasted valuation of USD 29.53 billion by the end of the period. The next-generation sequencing (NGS) market continues to grow steadily. A key driver of this expansion is the clinical adoption of NGS across oncology, rare diseases, reproductive health, and infectious diseases. This trend is also accompanied by lower cost per genome and the launch of higher-throughput benchtop and clinical instruments.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
In-Vitro Diagnostic (IVD) Market (Applications, End-users & Types) Trends & Global Forecasts (Major & Emerging Markets – G7, Japan & BRIC) (2011 - 2016)
The Asian region is expected to be ruled by the emerging economies such as China and India, show the highest CAGR by the year 2016. The Chinese IVD market is taking frog leap amongst the emerging nations, followed by India, Russia, and Brazil. The major driving factor for the IVD industry to boom in the emerging countries is the government funding and improved healthcare facilities.
- Published: January 2012
- Price: $ 4950
- TOC Available:
-
Interventional Cardiology Devices Market by Type [Stents (Drug-eluting Stent, Bare Metal Stent), Catheters (Angiography, Guiding, IVUS/OCT Catheter), Balloons, Plaque Modification Devices, Hemodynamic Flow Alteration], End User-Global Forecast to 2031
The global interventional cardiology devices market, valued at USD 29.41 billion in 2025, stood at USD 31.12 billion in 2026 and is projected to advance at a resilient CAGR of 6.4% from 2026 to 2031, culminating in a forecasted valuation of USD 42.39 billion by the end of the period. The growing preference for minimally invasive catheter-based procedures over conventional open-heart surgeries is further boosting the market, owing to advantages such as shorter hospital stays, faster recovery, and lower procedural risk.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Defibrillator Market by Product (Implantable Cardioverter Defibrillator, External Defibrillator (Automated Defibrillator, Wearable Defibrillator, Manual Defibrillator)), End User (Hospitals & Clinics, Cardiac Centers, Homecare) - Global Forecast to 2030
The global defibrillator market, valued at US$11.29 billion in 2024, stood at US$11.99 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$16.44 billion by the end of the period. Major players in the defibrillator market include Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Nihon Kohden Corporation (Japan), Biotronik (Germany), and CU Medical Systems, Inc. (South Korea).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Mobile Medical Applications & Social media for Health Market- Global Trends, Opportunities and Forecasts till 2017
Mobile applications or apps and smartphones are used in various areas of healthcare such as health education, data management, health management, work flow process, health information, etc. The healthcare industry demonstrated a relevant requisite for using mobile technology to assist its processes, so as to make health information access and support available almost everywhere that a mobile phone can go. Medical community is using smartphones and their applications for basic work at a higher rate than the general population, and is also using them for reporting in replacement for work that was previously done on a desktop or laptop computer.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Wireless Health Market by Technology (WPAN, WLAN/Wifi, WiMAX), Component (Hardware, Software, & Services), Application (Patient Specific and Provider/Payer Specific), & by End Users (Providers, & Payers) - Global Forecast to 2020
The global Wireless Health Market size is projected to grow at a CAGR of 23.1%. The market is segmented on the basis of technologies, components, applications, and end users. The market is expected to be dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (CRO, Pharma, Biotech, Medtech), Region - Forecast to 2030
The global eclinical solutions market, valued at USD 11.62 billion in 2024, stood at USD 13.18 billion in 2025 and is projected to advance at a resilient CAGR of 13.9% from 2025 to 2030, culminating in a forecasted valuation of USD 25.22 billion by the end of the period. The market is driven by the increasing adoption of digital technologies to improve clinical trial efficiency, data accuracy, and regulatory compliance.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) & Geography - Global Forecast to 2022
The clinical laboratory services market is expected to reach USD 146.41 billion by 2022 from USD 113.4 billion in 2017, at a CAGR of 5.2% during the forecast period. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others
- Published: December 2017
- Price: $ 4950
- TOC Available:
-
Outlook of Cardiac Pacemaker Market - Global Forecasts (2011-2016)
Pacemaker devices constitute a major segment in a rapidly expanding cardiovascular devices market. The global cardiac pacemakers market is characterized by relatively mature conditions and intense competition. However, an aging global population, and the subsequent rise in the incidence of cardiovascular diseases, has ensured a steady growth for the pacemakers market.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Erectile Dysfunction, Premature Ejaculation & Alopecia Market - Global Forecasts (2011-2016)
The development of erectile dysfunction is associated with an underlying cause which is organic in nature. Drug induced causes of erectile dysfunction are common and can complicate the medical management of underlying conditions such as hypertension, depression, and BPH. Beta blockers, selective serotonin reuptake inhibitors (SSRIs), and the uroselective alpha adrenergic receptor antagonists have been associated with the loss of libido or ejaculatory disorders, which can result in drug discontinuation by patients and suboptimal treatment of these conditions.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
